Dento-alveolar surgeries in patients using bisphosphonates
DOI:
https://doi.org/10.33448/rsd-v11i12.34510Keywords:
Bisphosphonate; Osteonecrosis; Jaw; Dentistry.Abstract
Bisphosphonates (BFs), such as alendronate, risedronate, ibandronate, and clodronate, are potent osteoclast-inhibiting drugs and are considered the first-choice therapy in diseases that affect bone metabolism. A significant adverse effect seen in patients using oral or intravenous BPs who have undergone invasive dental procedures such as implant therapy is bisphosphonate-related osteonecrosis of the jaw (OMRB), which is clinically characterized by painful exposure of bone in the maxillofacial region. In this sense, this study aims to review the literature on the protocol in dento-alveolar surgeries in patients using bisphosphonates, as well as to describe the clinical manifestations of drug-related mandibular osteonecrosis. For the construction of this article, a bibliographic survey was carried out in the databases SciVerse Scopus, Scientific Electronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) and ScienceDirect, with the help of the Mendeley reference manager. The articles were covered between the years 2010 to 2022. Osteonecrosis of the jaws caused by bisphosphonates is an uncommon, but potentially very serious, adverse consequence of drug therapy for BP. It is mainly associated with the use of more potent amino-bisphosphonates for long periods of time. The most common antecedent event to the development of clinical lesions is invasive dental treatment, and it is therefore particularly important that oral health professionals have an understanding of their causes and management. Prevention remains the most important aspect of management and begins at the time of first prescription and should continue for the rest of the patient's life because of the lasting effect of these drugs on bone.
References
De Almeida Freire, N., Heimlich, F. V., Ramos, M. E. B., Antero, S. A. F., & Israel, M. S. 2020. “Prevention Protocol For Bisphosphonate-Related Osteonecrosis Of The Jaws In A Patient With Hiv.” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 129(1):e131–32. https://doi.org/10.1016/j.oooo.2019.06.575.
Alzoman, H. A. 2011. “Prevalence of Jaw Osteonecrosis among Patients Receiving Bisphosphonates in Riyadh.” King Saud University Journal of Dental Sciences 2(1):29–32. https://doi.org/10.1016/j.ksujds.2011.03.001.
Bernardinho, Í. M., Leal, T. R., Filho, R. A. M., & Gomes, G. D.. 2009. Osteonecrose Dos Maxilares Associada À Utilização De Bisfosfonatos: Quais As Evidências Científicas Atuais? Vol. 3322.
Brozoski, M. A., Traina, A. A., Deboni, M. C. Z., Marques, M. M., & Naclério-Homem, M. G. 2012. “Osteonecrose Maxilar Associada Ao Uso de Bisfosfonatos.” Revista Brasileira de Reumatologia 52(2):265–70. 10.1590/s0482-50042012000200010.
Colella, G., Campisi, G., & Fusco, V. 2009. “American Association of Oral and Maxillofacial Surgeons Position Paper: Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update: The Need to Refine the BRONJ Definition.” Journal of Oral and Maxillofacial Surgery 67(12):2698–99. https://doi.org/10.1016/j.joms.2009.07.097.
Graves, L. L., Bukata, S. V., Aghazadehsanai, Nona., Chang, T. I., Garrett, N. R., & Friedlander, A. H.. 2016. “Patients Receiving Parenteral Bisphosphonates for Malignant Disease and Having Developed an Atypical Femoral Fracture Are at Risk of Concomitant Osteonecrosis of the Jaw: An Evidence-Based Review.” Journal of Oral and Maxillofacial Surgery 74(12):2403–8. https://doi.org/10.1016/j.joms.2016.06.003.
Hidaka, K., Mikuni-Takagaki, Y., Wada-Takahashi, S., Saita, M., Kawamata, R., Sato, Takenori., Kawata, A., Miyamoto, C., Maehata, Y., Watabe, H., Tani-Ishii, N., Hamada, N., Takahashi, S., Deguchi, S., & Takeuchi, R. 2019. “Low-Intensity Pulsed Ultrasound Prevents Development of Bisphosphonate-Related Osteonecrosis of the Jaw-Like Pathophysiology in a Rat Model.” Ultrasound in Medicine & Biology 45(7):1721–32. https://doi.org/10.1016/j.ultrasmedbio.2019.02.015.
Koyama, C., Hirota, M., Okamoto, Y., Iwai, T., Ogawa, T., Hayakawa, T., & Mitsudo, K. 2020. “A Nitrogen-Containing Bisphosphonate Inhibits Osteoblast Attachment and Impairs Bone Healing in Bone-Compatible Scaffold.” Journal of the Mechanical Behavior of Biomedical Materials 104:103635. https://doi.org/10.1016/j.jmbbm.2020.103635.
McLeod, N. M. H., Brennan, P. A., & Ruggiero, S. L.. 2012. “Bisphosphonate Osteonecrosis of the Jaw: A Historical and Contemporary Review.” The Surgeon 10(1):36–42. https://doi.org/10.1016/j.surge.2011.09.002.
Menga, E. N., Webb, A. J., & Mesfin, A. 2018. “Do Bisphosphonates Affect Fusion Rates? How to Manage These Medications in the Perioperative Time Frame.” Seminars in Spine Surgery 30(1):46–48. https://doi.org/10.1053/j.semss.2017.09.009.
Nadar, R. A., Franssen,G. M. Van Dijk, N. W. M. Codee-van der Schilden, K., de Weijert, M., Oosterwijk, E., Iafisco, M., Margiotta, N., Heskamp, S., van den Beucken, J. J. J. P., & Leeuwenburgh, S. C. G. 2021. “Bone Tumor–Targeted Delivery of Theranostic 195mPt-Bisphosphonate Complexes Promotes Killing of Metastatic Tumor Cells.” Materials Today Bio 9:100088. https://doi.org/10.1016/j.mtbio.2020.100088.
Nisi, M., La Ferla, F., Karapetsa, D., Gennai, S., Miccoli, M., Baggiani, A., Graziani, F., & Gabriele, M.. 2015. “Risk Factors Influencing BRONJ Staging in Patients Receiving Intravenous Bisphosphonates: A Multivariate Analysis.” International Journal of Oral and Maxillofacial Surgery 44(5):586–91. https://doi.org/10.1016/j.ijom.2015.01.014.
Patntirapong, S., Phupunporn, P., Vanichtantiphong, D., & Thanetchaloempong, W. 2019. “Inhibition of Macrophage Viability by Bound and Free Bisphosphonates.” Acta Histochemica 121(4):400–406. https://doi.org/10.1016/j.acthis.2019.02.007.
Rogers, M. J., D. Ph, S. Gordon, D. Ph, H. L. Benford, B. Sc, S. P. Luckman, and D. Ph. 2015. “Bisphosphonates.”
Santini, D., Vespasiani Gentilucci, U., Vincenzi, B., Picardi, A., Vasaturo, F., La Cesa, A., Onori, N., Scarpa, S., & Tonini, G.. 2003. “The Antineoplastic Role of Bisphosphonates: From Basic Research to Clinical Evidence.” Annals of Oncology 14(10):1468–76. doi: https://doi.org/10.1093/annonc/mdg401.
Santos, P. S. S., Gambirazi, L. M., Felix, V. B., & Magalhães, M. H. C. G.. 2008. “Osteonecrose Maxilar Em Pacientes Portadores de Doenças Neoplásicas Sob Uso de Bisfosfonatos.” Revista Brasileira de Hematologia e Hemoterapia 30(6):0–3. 10.1590/s1516-84842008000600016.
Vuorimies, I., Arponen, H., Valta, H., Tiesalo, O., Ekholm, M, Ranta, H., Evälahti, M., Mäkitie, O., & Waltimo-Sirén, J. 2017. “Timing of Dental Development in Osteogenesis Imperfecta Patients with and without Bisphosphonate Treatment.” Bone 94:29–33. https://doi.org/10.1016/j.bone.2016.10.004.
Yamashita, J,, Sawa, N., Sawa, Y., & Miyazono, S. 2021. “Effect of Bisphosphonates on Healing of Tooth Extraction Wounds in Infectious Osteomyelitis of the Jaw.” Bone 143:115611. https://doi.org/10.1016/j.bone.2020.115611.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Gildo Renê Sousa Ferreira ; Marcelo Costa Rodrigues ; Grace Kelly Martins Carneiro ; Kaio Henrique da Silva Carneiro ; Francine Militão dos Santos; Josiane Dias de Freitas Machado; Geraldo Soprani Júnior; Isabella Pulino Padilha; Ingrid Bruna de Menezes Rabelo ; Flávia Renata de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
